Transforming the Treatment Landscape of Autoimmune Diseases with Glycostem’s NK Cell Therapies
Time: 1:00 pm
day: Day Two Track A, PM
Details:
- uNiKTM: from umbilical cord blood hematopoietic stem cells to clinically safe and efficient off-the-shelf NK cells
- viveNK® CAR-NK cells employ multimodal synergistic enhancement of antigen-specific targeting against SLE B cells
- How to assess B cells depletion in autoimmune diseases? Are they really gone?
